trial

Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia

NCTId NCT04220099
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 30 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2020-06-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2020-01-07
Primary completion
2020-06-05
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Electroconvulsive therapy(ECT)

Sponsors

Shanghai Mental Health CenterLead Sponsor

Investigators

1
Zhen Wang, Ph.D M.DPrincipal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2020-06-05
Status
COMPLETED
relationships
The graph out of here
drug
Electroconvulsive therapy(ECT)
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Zhen Wang, Ph.D M.D
person